Browse studies
Find your next paid study
134 recruiting studies matching your filters
Phase 2
Benefit of Venetoclax Addition ("Benefit VA") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
People who have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are often treated with ibrutinib, acalabrutinib, or zanubrutinib. These …
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
VA Office of Research and DevelopmentNCT06520098
Phase 2
A Phase 2 Study of Nemtabrutinib and Venetoclax as Frontline Treatment for Chronic Lymphocytic Leukemia (CLL)
This phase II trial tests how well nemtabrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma…
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Jennifer WoyachNCT07557056